Riverwood Capital

Speciality Medicines IPO Description – Speciality Medicines is a leading pharmaceutical company engaged in the marketing and distribution of specialty pharmaceutical products, including high-cost oral and injectable medications for complex and chronic medical conditions. The company operates across therapeutic areas such as oncology, immunology, neurology, and rare diseases. Its extensive product portfolio, as of 31 March […]

Jagsonpal Pharmaceuticals Buyback Record Date is not finalized.  Jagsonpal Pharmaceuticals is a pharmaceutical company engaged in the manufacturing and marketing of branded generic formulations across multiple therapeutic segments. Jagsonpal primarily focuses on the domestic formulations market and has built a presence in therapy areas such as gastroenterology, dermatology, pain management, anti-infectives, and nutritional supplements. The

If you’ve been tracking IPO market, this news is critically important for you. On 13 March 2026, the government of India officially updated the rules for Initial Public Offerings (IPOs) to make it easier for “mega” companies to go public. Here is a simple breakdown of what these changes mean for you as a retail

The Securities and Exchange Board of India (SEBI) gave observation letters to three companies during the second week of March 2026. Conversely, two companies had their offer documents either withdrawn or returned by the regulator. Below is the list of the latest IPO approvals this week. Tea Post IPO Approval Tea Post is a prominent

Narmada Macplast Rights Issue dates is not finalized. Narmada Macplast Drip Irrigation Systems is a micro-irrigation solutions provider focused on water management products for the agriculture sector. The company operates in the manufacturing and supply of drip irrigation systems, PVC pipes, and related irrigation components designed to improve water efficiency and crop productivity. Narmada Macplast’s